Back to Opioid Epidemic: From Evidence to Impact
Johns Hopkins University

Opioid Epidemic: From Evidence to Impact

While prescription opioids serve an invaluable role for the treatment of cancer pain and pain at the end of life, their overuse for acute and chronic non-cancer pain as well as the increasing availability of heroin and illicit fentanyl, have contributed to the highest rates of overdose and opioid addiction in U.S. history. Evidence-informed solutions are urgently needed to address these issues and to promote high-quality care for those with pain. This course and the report it is based on are a response to that need. They offer timely information and a path forward for all who are committed to addressing injuries and deaths associated with opioids in the United States.

Status: Trend Analysis
Status: Substance Abuse
BeginnerCourse7 hours

Featured reviews

IA

5.0Reviewed May 22, 2020

Amazing course! I have learned so much from the wide array of lecturers and I am now planning on specialising on this subject through my MPH next year

KR

5.0Reviewed Mar 13, 2023

A wealth of information. I enjoyed this course and would be very interested in taking similar courses.

AA

5.0Reviewed Aug 23, 2022

This course was very helpful in understanding the extent of the problem and the kind of solutions that can be there. It will help me to look at the issue in a different light.

CS

5.0Reviewed Jun 14, 2022

G​ood, informative course that taught me a lot on the opioid epidemic and the ways to help combat this overbearing issue.

FG

5.0Reviewed Feb 24, 2020

Excellent course with really key figures presenting the research and collaborative work in this evolving epidemic ty to all

LD

5.0Reviewed Mar 15, 2022

This course is an excellent resource for people interested in pursuing a career in public health or working with people in many disciplines.

All reviews

Showing: 16 of 16

Libby D
5.0
Reviewed Mar 16, 2022
Fadi Ghanem
5.0
Reviewed Feb 24, 2020
Jilann zamborsky-Medina
5.0
Reviewed Oct 14, 2022
Saul G
5.0
Reviewed Jul 5, 2023
Arshdeep Arshi
5.0
Reviewed Aug 24, 2022
Isabelle-Maria Arusilor
5.0
Reviewed May 23, 2020
Cooper Schirmeier
5.0
Reviewed Jun 15, 2022
Kimberly Robbins
5.0
Reviewed Mar 14, 2023
craig schroder
5.0
Reviewed Feb 4, 2022
Golyad Woldu
5.0
Reviewed Feb 6, 2024
Jp Bustamante
5.0
Reviewed Mar 10, 2021
Mfon Israel Victor
5.0
Reviewed Sep 23, 2020
Stephanie Lilliman
3.0
Reviewed Apr 6, 2020
James Morris
3.0
Reviewed Dec 24, 2021
A. F. M. Moazzem Hossain Bhuiyan
3.0
Reviewed Jul 1, 2020
Peter Williams
1.0
Reviewed Oct 6, 2022